1857-P: Three-Year Sustainability of Glycemic Outcomes in Latin American Users of the MiniMed 780G System
MATIAS CASTRO, Bruno A. Grassi, Alejandro Daín, Eduardo P Luis Calliari et autres
Introduction and Objective: Automated insulin delivery (AID) systems have demonstrated clinical benefits in Latin America (LATAM)1. While AID therapy benefits are well established, evidence of sustained real-world performance is critical to support broader adoption and long-term regional implementation. This analysis reports 3-year …